Journal
MOLECULAR NUTRITION & FOOD RESEARCH
Volume 61, Issue 10, Pages -Publisher
WILEY
DOI: 10.1002/mnfr.201700111
Keywords
Bioavailability; Brain; Diabetes; Grape polyphenols; Pharmacokinetics
Categories
Funding
- U.S. National Institutes of Health [PO1 AT004511]
- NCCIH [P50 AT008661-01]
- ODS
Ask authors/readers for more resources
Scope: The effect of diabetes on the pharmacokinetics, bioavailability and brain distribution of grape polyphenols and select metabolites was studied in the Zucker diabetic fatty (ZDF) rat model. Methods and results: (ZDF) rats and their lean controls (LN) were dosed with a Standardized Grape Polyphenol (SGP) Mixture consisting of grape seed extract, Concord grape juice and resveratrol (RES) by oral gavage for 10 days. An 8-h pharmacokinetic study was performed. After 24h, a second dose of SGP was administered and 1h later animals were sacrificed and brain tissue was harvested. Plasma, urine, and brain tissue were analyzed for grape polyphenols. ZDF rats exhibited significantly diminished C-max for all catechin, epicatechin, quercetin and resveratrol conjugated metabolites. Bioavailability was significantly lower in ZDF rats for methylated flavan-3-ol, RES, and quercetin metabolites. Significantly lower levels of metabolites of RES, quercetin, and flavan-3-ols were found in brains of ZDF rats. There was no significant difference between ZDF and LN in anthocyanins in plasma and no anthocyanins were detectable in brain extracts. ZDF rats showed significantly higher urinary excretion for all polyphenols. Conclusion: Diabetes may alter the overall bioavailability of some polyphenols in plasma and brain in part due to higher urinary clearance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available